Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (1868)	4/27/2007 3:40:37 PM
From: Art Bechhoefer	Respond to of 1870

Tuck, it would not surprise me at all to see this kind of shenanigans going on in regulatory agencies, particularly the FDA, which has long been influenced by more powerful drug company interests. You can call it conspiracy theory, but I call it greed, pure and simple: Antisense technology has been shown to be an often superior method for treating cancers and other illnesses not susceptible to cures with any other existing drugs. The purpose for making negative and/or misleading analyses is to drive the company so close to bankruptcy, if not into bankruptcy, leaving it open to an outside purchaser, who gets valuable intellectual property at a bargain basement price. Being an investment advisor, and having studied literally thousands of small companies, I have seen this scenario enacted numerous times. All it takes are compliant regulators and a justice system primed to help the rich. Art